SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Surgery Partners, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$14.71+0.10 (+0.68%)
Close on Oct 19, 2026
- Market cap
- $1.90B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$5.88 (−28.56%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Surgery Partners, Inc. grew revenue 4.0% to $3.37B over the twelve months to Jun 30, 2026. Operating income rose 6.1% to $383.80M, moving the operating margin from 11.2% to 11.4%. Free cash flow was $187.60M, up 7.0% from a year earlier.
Revenue
$3.37B
+4.0% vs. a year earlier
Operating income
$383.80M
+6.1% vs. a year earlier
Free cash flow
$187.60M
+7.0% vs. a year earlier
EPS, diluted
-$0.70
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.90B
- P/E ratio
- –
- Price to sales
- 0.56
- Price to book
- 1.13
- Dividend yield
- –
- Free cash flow yield
- 9.90%
Fundamentals
- Revenue
- $3.37B
- Net income
- -$88.60M
- EPS, diluted
- -$0.70
- Free cash flow
- $187.60M
- Book value per share
- $12.97
- Diluted shares
- 129M
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
$3.37B+4.0% YoY
Gross profit
–
Operating income
$383.80M+6.1% YoY
Net income
-$88.60M
EPS, diluted
-$0.70
Free cash flow
$187.60M+7.0% YoY
Reported periodTrailing twelve months